These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 946183)

  • 1. Hepatitis B surface antigen and antibody in asymptomatic blood donors.
    Sinclair JC; Feinman SV; Wrobel DM; Berris B
    JAMA; 1976 Mar; 235(10):1014-7. PubMed ID: 946183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.
    Stimmel B; Vernace S; Schaffner F
    JAMA; 1975 Dec; 234(11):1135-8. PubMed ID: 810605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis and hepatitis B surface antigen and antibody in dentists.
    Berris B; Feinman SV; Sinclair JC; Wrobel D
    Can Med Assoc J; 1978 Nov; 119(9):1040-3. PubMed ID: 743666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination.
    Tsuda F; Takahashi T; Takahashi K; Miyakawa Y; Mayumi M
    J Immunol; 1975 Sep; 115(3):834-8. PubMed ID: 1171142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of radioimmunoassay and counterimmunoelectrophoresis for the detection of hepatitis B surface antigen carriers in a high-prevalence region.
    Sandler SG; Knecht A; Amar A; Davidowitch R
    Isr J Med Sci; 1979 Jul; 15(7):579-82. PubMed ID: 478821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver enzyme concentrations as measure of possible infectivity in chronic asymptomatic carriers of hepatitis B.
    Barbara JA; Mijovic V; Cleghorn TE; Tedder RS; Briggs M
    Br Med J; 1978 Dec; 2(6152):1600-2. PubMed ID: 728740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.
    Hoofnagle JH; Gerety RJ; Ni LY; Barker LF
    N Engl J Med; 1974 Jun; 290(24):1336-40. PubMed ID: 4827644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of highly sensitive methods of detecting hepatitis B virus markers for studying epidemic foci of hepatitis B].
    Mukomolov SL; Arakelov SA; Shliakhtenko LI; Anan'ev VA; Nechaev VV
    Vopr Virusol; 1985; 30(1):71-5. PubMed ID: 3887758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [e-Antigen and antibody in HBsAg carriers and liver diseases in Taiwan (author's transl)].
    Liaw YF; Chang-Chien CS; Huang MJ; Lin DY; Wu CS; Chen PC
    Taiwan Yi Xue Hui Za Zhi; 1979 Jul; 78(7):635-40. PubMed ID: 291687
    [No Abstract]   [Full Text] [Related]  

  • 20. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.